MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia	https://doi.org/10.1002/pbc.23279	2012	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 6 Master/Detail View
MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways	https://doi.org/10.1371/journal.pone.0056334	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 18 Master/Detail View
Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia	https://doi.org/10.2147/OTT.S36017	2012	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia	https://doi.org/10.3892/or.2015.3787	2015	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia	https://doi.org/10.1186/1475-2867-13-110	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment	https://doi.org/10.18632/oncotarget.10577	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 24 Master/Detail View
Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma	https://doi.org/10.4161/cc.8.1.7292	2009	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma	https://doi.org/10.1016/j.bbrc.2010.08.015	2010	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 4 Master/Detail View
Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group	https://doi.org/10.1158/1078-0432.CCR-10-0091	2011	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 5 Master/Detail View
miR-181a promotes G1/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM	https://doi.org/10.1007/s00432-015-1995-1	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1	https://doi.org/10.1186/1476-4598-13-123	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma	https://doi.org/10.3390/cancers11091380	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors	https://doi.org/10.1158/0008-5472.CAN-09-3970	2010	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 26 Master/Detail View
MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d Expressions in Hepatoblastoma and Clinical Importance	https://doi.org/10.1097/MPH.0000000000001234	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
MicroRNA expression might predict prognosis of epithelial hepatoblastoma	https://doi.org/10.1007/s00428-014-1549-y	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 10 Master/Detail View
Effect of miR-21 on apoptosis in hepatoblastoma cell through activating ASPP2/p38 signaling pathway in vitro and in vivo	https://doi.org/10.1080/21691401.2019.1664561	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Altered microRNA Expression Patterns in Hepatoblastoma Patients	https://doi.org/10.1593/tlo.09124	2009	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 5 Master/Detail View
Solid tumors of childhood display specific serum microRNA profiles	https://doi.org/10.1158/1055-9965.EPI-14-0669	2015	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 14 Master/Detail View
Solid tumors of childhood display specific serum microRNA profiles	https://doi.org//10.1158/1055-9965.EPI-14-0669	2015	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group	https://doi.org/10.1002/pbc.26157	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View

Publications